Global Blog

AI Breathes New Life into Clinical Trials: Perspectives and Challenges

Artificial intelligence is transforming the world of clinical trials, promising to cut drug development timelines in half.

Orange bets on AI for network optimization, automation

Artefact mentioned in this interview from Brelotte Ba, deputy CEO of Orange Middle East and Africa, by Connecting Africa, on Orange's latest AI and GenAI...

Compound AI Systems: The Future of Specialized Intelligence

Since its explosive emergence in mid-2022, generative AI has quickly captured global attention. What initially centered on the language modality has since expanded into exciting...

Is GenAI hype dying? – Why now is the best time to build

Generative AI is a game-changer with applications across industries. Companies are actively discussing it, venture capitalists are heavily investing, and both employees and users are...

Is Preference Alignment Always the Best Option to Enhance LLM-Based Translation? An Empirical Analysis

Neural metrics for machine translation (MT) evaluation have become increasingly prominent due to their superior correlation with human judgments compared to traditional lexical metrics

Unleashing the power of AI in Clinical Trials: Key Insights from PFIZER and ARTEFACT - AI for Health Summit

The discussion revolved around the transformative role of AI in clinical trials, supported by insights from Pfizer and Artefact, and highlighted in their collaborative white...

CLARIANE and CNES MEDES at AI for Health - Preventing frailty and AI-geing well

The conversation explores how data and AI are transforming elder care, focusing on the rising demographic of seniors in France, where 20% of the population...

SANOFI, AWS, IKTOS, ELAIA and MIND GROUP at AI for Health - The generative AI revolution for drug discovery

This roundtable explored the transformative role of GenAI in drug discovery, highlighting its potential to optimize processes, accelerate timelines, and foster collaboration in the pharmaceutical...

ROCHE, PULSELIFE and SALESFORCE at the AI for Health Summit - Omni-channel engagement of HCPs in the Age of GenAI

The roundtable focused on the transformative potential of AI and (GenAI) in omni-channel engagement for healthcare professionals (HCPs). The discussion explored how AI reshapes interactions,...

PFIZER at the AI for Health Summit - AI: On a mission to make drug development faster and smarter

Pfizer is leveraging AI to revolutionize drug development. AI is viewed as a game-changer, impacting every stage of the pharmaceutical process, from preclinical research to...

Leaders' POV: Accelerating drug innovation through AI at SERVIER - AI for Health Summit

Servier has approached AI adoption in two phases. Initially, an opportunistic approach focused on proving AI's potential through specific use cases, especially in collaboration with...

AMGEN, BIOGEN, Johnson & Johnson, USE&SHARE, APHP at the AI for Health Summit - Strategic vision for rare diseases

This roundtable at the AI for Health Summit 2024 focused on the use of health data and artificial intelligence to address diagnostic delays and impasses...